The Paul G. Allen Frontiers Group, a division of Seattle’s Allen Institute, is making a total of $7.5 million in awards to its latest class of five biomedical researchers.
The themes for this year’s Allen Distinguished Investigators focus on stem cell therapies and single-cell interactions in their native environments.
“The field of stem cell biology has the potential to change how we treat diseases by helping precision medicine, and there’s so much we still don’t understand about the interplay between cells in living tissues or organs,” Kathy Richmond, director of the Frontiers Group, said today in a news release.
Comments are closed.